Skip to main content

Novel calculator more easily identifies patients who will benefit from neoadjuvant chemoradiation

A calculator to guide treatment choice in esophageal cancer has been developed by a team of researchers. The tool helps identify which patients may benefit from treatment before surgery.
https://www.sciencedaily.com/releases/2017/03/170302133901.htm

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino